Their final consensus list was conformed by 99 mutational BC driver genes, of them, 34 were identified by the OncoOmics strategy (TP53, PIK3CA, KMT2C, GATA3, CDH1, MAP3K1, ESR1, PTEN, AKT1, NCOR1, ARID1A, MAP2K4, FOXA1, NF1, ERBB2, RB1, SF3B1, ERBB3, CTCF, PIK3R1, ATM, FGFR2, BRCA1, CASP8, CREBBP, BRCA2, CDKN2A, KRAS, CDKN1B, NOTCH2, MAX, MDM4, EGFR and JAK2). This evidence concerns the gene TP53 and breast cancer.